The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Cannabis-based medicines for chronic neuropathic pain in adults
Open accessAbstract
BACKGROUND: This review is one of a series on drugs used to treat chronic neuropathic pain. Estimates of the population prevalence of chronic pain with neuropathic components range between 6% and 10%. Current pharmacological treatment options for neuropathic pain afford substantial benefit for only a few people, often with adverse effects that outweigh the benefits. There is a need to explore other treatment options, with different mechanisms of action for treatment of conditions with chronic neuropathic pain. Cannabis has been used for millennia to reduce pain. Herbal cannabis is currently strongly promoted by some patients and their advocates to treat any type of chronic pain. OBJECTIVES: To assess the efficacy, tolerability, and safety of cannabis-based medicines (herbal, plant-derived, synthetic) compared to placebo or conventional drugs for conditions with chronic neuropathic pain in adults. SEARCH METHODS: In November 2017 we searched CENTRAL, MEDLINE, Embase, and two trials registries for published and ongoing trials, and examined the reference lists of reviewed articles. SELECTION CRITERIA: We selected randomised, double-blind controlled trials of medical cannabis, plant-derived and synthetic cannabis-based medicines against placebo or any other active treatment of conditions with chronic neuropathic pain in adults, with a treatment duration of at least two weeks and at least 10 participants per treatment arm. DATA COLLECTION AND ANALYSIS: Three review authors independently extracted data of study characteristics and outcomes of efficacy, tolerability and safety, examined issues of study quality, and assessed risk of bias. We resolved discrepancies by discussion. For efficacy, we calculated the number needed to treat for an additional beneficial outcome (NNTB) for pain relief of 30% and 50% or greater, patient's global impression to be much or very much improved, dropout rates due to lack of efficacy, and the standardised mean differences for pain intensity, sleep problems, health-related quality of life (HRQoL), and psychological distress. For tolerability, we calculated number needed to treat for an additional harmful outcome (NNTH) for withdrawal due to adverse events and specific adverse events, nervous system disorders and psychiatric disorders. For safety, we calculated NNTH for serious adverse events. Meta-analysis was undertaken using a random-effects model. We assessed the quality of evidence using GRADE and created a 'Summary of findings' table. MAIN RESULTS: We included 16 studies with 1750 participants. The studies were 2 to 26 weeks long and compared an oromucosal spray with a plant-derived combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) (10 studies), a synthetic cannabinoid mimicking THC (nabilone) (two studies), inhaled herbal cannabis (two studies) and plant-derived THC (dronabinol) (two studies) against placebo (15 studies) and an analgesic (dihydrocodeine) (one study). We used the Cochrane 'Risk of bias' tool to assess study quality. We defined studies with zero to two unclear or high risks of bias judgements to be high-quality studies, with three to five unclear or high risks of bias to be moderate-quality studies, and with six to eight unclear or high risks of bias to be low-quality studies. Study quality was low in two studies, moderate in 12 studies and high in two studies. Nine studies were at high risk of bias for study size. We rated the quality of the evidence according to GRADE as very low to moderate.Primary outcomesCannabis-based medicines may increase the number of people achieving 50% or greater pain relief compared with placebo (21% versus 17%; risk difference (RD) 0.05 (95% confidence interval (CI) 0.00 to 0.09); NNTB 20 (95% CI 11 to 100); 1001 participants, eight studies, low-quality evidence). We rated the evidence for improvement in Patient Global Impression of Change (PGIC) with cannabis to be of very low quality (26% versus 21%;RD 0.09 (95% CI 0.01 to 0.17); NNTB 11 (95% CI 6 to 100); 1092 participants, six studies). More participants withdrew from the studies due to adverse events with cannabis-based medicines (10% of participants) than with placebo (5% of participants) (RD 0.04 (95% CI 0.02 to 0.07); NNTH 25 (95% CI 16 to 50); 1848 participants, 13 studies, moderate-quality evidence). We did not have enough evidence to determine if cannabis-based medicines increase the frequency of serious adverse events compared with placebo (RD 0.01 (95% CI -0.01 to 0.03); 1876 participants, 13 studies, low-quality evidence).Secondary outcomesCannabis-based medicines probably increase the number of people achieving pain relief of 30% or greater compared with placebo (39% versus 33%; RD 0.09 (95% CI 0.03 to 0.15); NNTB 11 (95% CI 7 to 33); 1586 participants, 10 studies, moderate quality evidence). Cannabis-based medicines may increase nervous system adverse events compared with placebo (61% versus 29%; RD 0.38 (95% CI 0.18 to 0.58); NNTH 3 (95% CI 2 to 6); 13
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
(2008) · Cited by 3,790
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Adverse health effects of marijuana use.
Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1402309 · Cited by 2,774
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Neuropathic pain in the general population: A systematic review of epidemiological studies
van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H., & Torrance, N. (2014) · Pain · doi:10.1016/j.pain.2013.11.013 · Cited by 1,602
A new definition of neuropathic pain
Jensen, T. S., Baron, R., Haanpää, M., Kalso, E., Loeser, J. D., Rice, A. S. C., & Treede, R.-D. (2011) · Pain · doi:10.1016/j.pain.2011.06.017 · Cited by 1,427
Meta-Analysis in Clinical Research
L'ABBÉ, K. A., DETSKY, A. S., & O'ROURKE, K. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-224 · Cited by 1,267
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes
Guyatt, G. H., Oxman, A. D., Santesso, N., Helfand, M., Vist, G., Kunz, R., Brozek, J., Norris, S., Meerpohl, J., Djulbegovic, B., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.012 · Cited by 836
Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827
Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms
von Hehn, C. A., Baron, R., & Woolf, C. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.008 · Cited by 800
Guyatt, G., Oxman, A. D., Sultan, S., Brozek, J., Glasziou, P., Alonso-Coello, P., Atkins, D., Kunz, R., Montori, V., Jaeschke, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.006 · Cited by 762
Pregabalin for acute and chronic pain in adults
Moore, R. A., Straube, S., Wiffen, P. J., Derry, S., & McQuay, H. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007076.pub2 · Cited by 762
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679
The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews
Turner, R. M., Bird, S. M., & Higgins, J. P. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059202 · Cited by 672
Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles
Baron, R., Maier, C., Attal, N., Binder, A., Bouhassira, D., Cruccu, G., Finnerup, N. B., Haanpää, M., Hansson, P., Hüllemann, P., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000000753 · Cited by 611
Moore, A. R., Gavaghan, D., Tramèr, R. M., Collins, L. S., & McQuay, J. H. (1998) · Pain · doi:10.1016/s0304-3959(98)00140-7 · Cited by 604
Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., Reda, H., Press, S., Kelly, M. E., Rowbotham, M. C., & Petersen, K. L. (2007) · Neurology · doi:10.1212/01.wnl.0000253187.66183.9c · Cited by 598
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
An Evidence-Based Resource for Pain Relief
McQuay, H., & Moore, R. A. (1998) · Medical Entomology and Zoology · Cited by 569
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
Lunn, M. P., Hughes, R. A., & Wiffen, P. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007115.pub3 · Cited by 565
Gabapentin for chronic neuropathic pain in adults
Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R., Phillips, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub4 · Cited by 561
Self-citationSmall study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
Nuesch, E., Trelle, S., Reichenbach, S., Rutjes, A. W. S., Tschannen, B., Altman, D. G., Egger, M., & Juni, P. (2010) · BMJ · doi:10.1136/bmj.c3515 · Cited by 559
Topical capsaicin (high concentration) for chronic neuropathic pain in adults
Derry, S., Rice, A. S., Cole, P., Tan, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007393.pub4 · Cited by 559
Influence of trial sample size on treatment effect estimates: meta-epidemiological study
Dechartres, A., Trinquart, L., Boutron, I., & Ravaud, P. (2013) · BMJ · doi:10.1136/bmj.f2304 · Cited by 544
Moulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., et al. (2014) · Pain Research and Management · doi:10.1155/2014/754693 · Cited by 529
Svendsen, K. B., Jensen, T. S., & Bach, F. W. (2004) · BMJ · doi:10.1136/bmj.38149.566979.ae · Cited by 500
Incidence of facial pain in the general population
Koopman, J. S. H. A., Dieleman, J. P., Huygen, F. J., de Mos, M., Martin, C. G. M., & Sturkenboom, M. C. J. M. (2009) · Pain · doi:10.1016/j.pain.2009.08.023 · Cited by 489
The Endocannabinoid System and Pain
Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476
Novotna, A., Mares, J., Ratcliffe, S., Novakova, I., Vachova, M., Zapletalova, O., Gasperini, C., Pozzilli, C., Cefaro, L., Comi, G., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03328.x · Cited by 475
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
Ellis, R. J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., Gouaux, B., Bentley, H., & Atkinson, J. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.120 · Cited by 461
Interventional management of neuropathic pain: NeuPSIG recommendations
Dworkin, R. H., O’Connor, A. B., Kent, J., Mackey, S. C., Raja, S. N., Stacey, B. R., Levy, R. M., Backonja, M., Baron, R., Harke, H., et al. (2013) · Pain · doi:10.1016/j.pain.2013.06.004 · Cited by 457
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Ware, M. A., Wang, T., Shapiro, S., Robinson, A., Ducruet, T., Huynh, T., Gamsa, A., Bennett, G. J., & Collet, J.-P. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091414 · Cited by 450
The role of the immune system in the generation of neuropathic pain
Calvo, M., Dawes, J. M., & Bennett, D. L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70134-5 · Cited by 445
Wade, D. T., Robson, P., House, H., Makela, P., & Aram, J. (2003) · Clinical Rehabilitation · doi:10.1191/0269215503cr581oa · Cited by 441
Demant, D. T., Lund, K., Vollert, J., Maier, C., Segerdahl, M., Finnerup, N. B., Jensen, T. S., & Sindrup, S. H. (2014) · Pain · doi:10.1016/j.pain.2014.08.014 · Cited by 440
Nurmikko, T. J., Serpell, M. G., Hoggart, B., Toomey, P. J., Morlion, B. J., & Haines, D. (2007) · Pain · doi:10.1016/j.pain.2007.08.028 · Cited by 431
Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials
Lynch, M. E., & Campbell, F. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03970.x · Cited by 397
Long, J. Z., Nomura, D. K., Vann, R. E., Walentiny, D. M., Booker, L., Jin, X., Burston, J. J., Sim-Selley, L. J., Lichtman, A. H., Wiley, J. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909411106 · Cited by 391
Andrew, R., Derry, S., Taylor, R. S., Straube, S., & Phillips, C. J. (2014) · Pain Practice · doi:10.1111/papr.12050 · Cited by 375
“Evidence” in chronic pain–establishing best practice in the reporting of systematic reviews
Moore, A. R., Eccleston, C., Derry, S., Wiffen, P., Bell, R. F., Straube, S., & McQuay, H. (2010) · Pain · doi:10.1016/j.pain.2010.05.011 · Cited by 370
Katusic, S., Williams, D. B., Beard, M., Bergstralh, E. J., & Kurland, L. T. (1991) · Neuroepidemiology · doi:10.1159/000110284 · Cited by 367
Berman, J. S., Symonds, C., & Birch, R. (2004) · Pain · doi:10.1016/j.pain.2004.09.013 · Cited by 362
Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome
Moore, R. A., Straube, S., & Aldington, D. (2013) · Anaesthesia · doi:10.1111/anae.12148 · Cited by 362
Clinical characteristics and economic costs of patients with painful neuropathic disorders
Berger, A., Dukes, E. M., & Oster, G. (2004) · The Journal of Pain · doi:10.1016/j.jpain.2003.12.004 · Cited by 351
Karst, M., Salim, K., Burstein, S., Conrad, I., Hoy, L., & Schneider, U. (2003) · JAMA · doi:10.1001/jama.290.13.1757 · Cited by 340
Imputing response rates from means and standard deviations in meta-analyses
Furukawa, T. A., Cipriani, A., Barbui, C., Brambilla, P., & Watanabe, N. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200501000-00010 · Cited by 337
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
Wilsey, B., Marcotte, T., Tsodikov, A., Millman, J., Bentley, H., Gouaux, B., & Fishman, S. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.12.010 · Cited by 327
Thorlund, K., Imberger, G., Walsh, M., Chu, R., Gluud, C., Wetterslev, J., Guyatt, G., Devereaux, P. J., & Thabane, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025491 · Cited by 319
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Wilsey, B., Marcotte, T., Deutsch, R., Gouaux, B., Sakai, S., & Donaghe, H. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2012.10.009 · Cited by 314
Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews
Wiffen, P. J., Derry, S., Moore, R. A., Aldington, D., Cole, P., Rice, A. S., Lunn, M. P., Hamunen, K., Haanpaa, M., & Kalso, E. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010567.pub2 · Cited by 306
Notcutt, W., Price, M., Miller, R., Newport, S., Phillips, C., Simmons, S., & Sansom, C. (2004) · Anaesthesia · doi:10.1111/j.1365-2044.2004.03674.x · Cited by 305
Trigeminal neuralgia: The role of self-sustaining discharge in the trigeminal ganglion
Rappaport, H. Z., & Devor, M. (1994) · Pain · doi:10.1016/0304-3959(94)90086-8 · Cited by 303
Langford, R. M., Mares, J., Novotna, A., Vachova, M., Novakova, I., Notcutt, W., & Ratcliffe, S. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6739-4 · Cited by 298
Sultan, A., Gaskell, H., Derry, S., & Moore, R. A. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-29 · Cited by 291
Amitriptyline for neuropathic pain in adults
Moore, R. A., Derry, S., Aldington, D., Cole, P., & Wiffen, P. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008242.pub3 · Cited by 286
Moore, R. A., Moore, O. A., Derry, S., Peloso, P. M., Gammaitoni, A. R., & Wang, H. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.107805 · Cited by 279
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
Zajicek, J. P., Hobart, J. C., Slade, A., Barnes, D., Mattison, P. G., & on behalf of the MUSEC Research Group (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302468 · Cited by 278
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy
Wallace, M. S., Marcotte, T. D., Umlauf, A., Gouaux, B., & Atkinson, J. H. (2015) · The Journal of Pain · doi:10.1016/j.jpain.2015.03.008 · Cited by 276
Expect analgesic failure; pursue analgesic success
Moore, A., Derry, S., Eccleston, C., & Kalso, E. (2013) · BMJ · doi:10.1136/bmj.f2690 · Cited by 271
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
Andreae, M. H., Carter, G. M., Shaparin, N., Suslov, K., Ellis, R. J., Ware, M. A., Abrams, D. I., Prasad, H., Wilsey, B., Indyk, D., et al. (2015) · The Journal of Pain · doi:10.1016/j.jpain.2015.07.009 · Cited by 266
GUSTORFF, B., DORNER, T., LIKAR, R., GRISOLD, W., LAWRENCE, K., SCHWARZ, F., & RIEDER, A. (2008) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2007.01486.x · Cited by 266
Lynch, M. E., Cesar-Rittenberg, P., & Hohmann, A. G. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.02.018 · Cited by 266
Attal, N., de Andrade, D. C., Adam, F., Ranoux, D., Teixeira, M. J., Galhardoni, R., Raicher, I., Üçeyler, N., Sommer, C., & Bouhassira, D. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00017-x · Cited by 253
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)
Ware, M. A., Wang, T., Shapiro, S., Collet, J.-P., Boulanger, A., Esdaile, J. M., Gordon, A., Lynch, M., Moulin, D. E., & O'Connell, C. (2015) · The Journal of Pain · doi:10.1016/j.jpain.2015.07.014 · Cited by 249
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
Corey-Bloom, J., Wolfson, T., Gamst, A., Jin, S., Marcotte, T. D., Bentley, H., & Gouaux, B. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110837 · Cited by 235
Association Between Analytic Strategy and Estimates of Treatment Outcomes in Meta-analyses
Dechartres, A., Altman, D. G., Trinquart, L., Boutron, I., & Ravaud, P. (2014) · JAMA · doi:10.1001/jama.2014.8166 · Cited by 233
Medicinal Use of Cannabis: History and Current Status
Kalant, H. (2001) · Pain Research and Management · doi:10.1155/2001/469629 · Cited by 212
Frank, B., Serpell, M. G., Hughes, J., Matthews, J. N. S., & Kapur, D. (2008) · BMJ · doi:10.1136/bmj.39429.619653.80 · Cited by 207
Moore, A. R., Straube, S., Paine, J., Phillips, C. J., Derry, S., & McQuay, H. J. (2010) · Pain · doi:10.1016/j.pain.2010.02.039 · Cited by 200
Serpell, M., Ratcliffe, S., Hovorka, J., Schofield, M., Taylor, L., Lauder, H., & Ehler, E. (2014) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00445.x · Cited by 197
Moore, A. R., Straube, S., Paine, J., Derry, S., & McQuay, H. J. (2011) · Pain · doi:10.1016/j.pain.2010.11.030 · Cited by 195
Selvarajah, D., Gandhi, R., Emery, C. J., & Tesfaye, S. (2010) · Diabetes Care · doi:10.2337/dc09-1029 · Cited by 189
Hillard, C. J., Weinlander, K. M., & Stuhr, K. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.020 · Cited by 187
Moore, A. R., Straube, S., Eccleston, C., Derry, S., Aldington, D., Wiffen, P., Bell, R. F., Hamunen, K., Phillips, C., & McQuay, H. (2012) · Pain · doi:10.1016/j.pain.2011.10.004 · Cited by 179
Topical lidocaine for neuropathic pain in adults
Derry, S., Wiffen, P. J., Moore, A., & Quinlan, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010958.pub2 · Cited by 175
Häuser, W., Petzke, F., & Fitzcharles, M. A. (2018) · European Journal of Pain · doi:10.1002/ejp.1118 · Cited by 175
Self-citationToth, C., Mawani, S., Brady, S., Chan, C., Liu, C., Mehina, E., Garven, A., Bestard, J., & Korngut, L. (2012) · Pain · doi:10.1016/j.pain.2012.06.024 · Cited by 174
Hall, G. C., Carroll, D., & McQuay, H. J. (2008) · BMC Family Practice · doi:10.1186/1471-2296-9-26 · Cited by 174
Straube, S., Derry, S., McQuay, H. J., & Moore, R. A. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03200.x · Cited by 173
Topical capsaicin (low concentration) for chronic neuropathic pain in adults
Derry, S., & Moore, R. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010111 · Cited by 173
Wissel, J., Haydn, T., Müller, J., Brenneis, C., Berger, T., Poewe, W., & Schelosky, L. D. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0218-8 · Cited by 171
Duloxetine use in chronic painful conditions – individual patient data responder analysis
Moore, R. A., Cai, N., Skljarevski, V., & Tölle, T. R. (2014) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00341.x · Cited by 169
Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
van Hoek, A. J., Gay, N., Melegaro, A., Opstelten, W., & Edmunds, W. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.12.024 · Cited by 156
Amygdala activity contributes to the dissociative effect of cannabis on pain perception
Lee, M., Ploner, M., Wiech, K., Bingel, U., Wanigasekera, V., Brooks, J. C. W., Menon, D. K., & Tracey, I. (2012) · Pain · doi:10.1016/j.pain.2012.09.017 · Cited by 155
Oxycodone for neuropathic pain in adults
Gaskell, H., Derry, S., Stannard, C., & Moore, R. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010692.pub3 · Cited by 153
Walitt, B. T., Klose, P., Fitzcharles, M., Phillips, T., & Häuser, W. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011694.pub2 · Cited by 152
Self-citationOral nonsteroidal anti-inflammatory drugs for neuropathic pain
Moore, A., Chi, C., Wiffen, P. J., Derry, S., & Rice, A. S. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010902.pub2 · Cited by 145
The burden of Herpes Zoster: A prospective population based study
SCOTT, F., Johnson, R., Leedham-Green, M., DAVIES, E., EDMUNDS, W., & Breuer, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.026 · Cited by 145
Boychuk, D., Goddard, G., Mauro, G., & Orellana, M. (2015) · Journal of Oral & Facial Pain and Headache · doi:10.11607/ofph.1274 · Cited by 140
Moore, R. A., Mhuircheartaigh, R. J. N., Derry, S., & McQuay, H. J. (2011) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e328343c569 · Cited by 138
Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients
Schimrigk, S., Marziniak, M., Neubauer, C., Kugler, E. M., Werner, G., & Abramov-Sommariva, D. (2017) · European Neurology · doi:10.1159/000481089 · Cited by 136
Moore, A. R., Smugar, S. S., Wang, H., Peloso, P. M. J., & Gammaitoni, A. R. (2010) · Pain · doi:10.1016/j.pain.2010.07.013 · Cited by 129
Pregabalin in fibromyalgia - responder analysis from individual patient data
Straube, S., Derry, S., Moore, R. A., Paine, J., & McQuay, H. J. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-150 · Cited by 128
Turcotte, D., Doupe, M., Torabi, M., Gomori, A., Ethans, K., Esfahani, F., Galloway, K., & Namaka, M. (2015) · Pain Medicine · doi:10.1111/pme.12569 · Cited by 124
Wie neuropathisch ist die Lumboischialgie?
Baron, R., & Binder, A. (2004) · Der Orthopäde · doi:10.1007/s00132-004-0645-0 · Cited by 123
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence
Jensen, B., Chen, J. L., Furnish, T. J., & Wallace, M. S. (2015) · Current Pain and Headache Reports · doi:10.1007/s11916-015-0524-x · Cited by 119
Cannabinoids in Pain Management and Palliative Medicine
Häuser, W., Fitzcharles, M., Radbruch, L., & Petzke, F. W. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0627 · Cited by 117
Self-citationKalso, E. A., Aldington, D. J., & Moore, R. A. (2013) · BMJ · doi:10.1136/bmj.f7339 · Cited by 110
Effect of Dronabinol on Central Neuropathic Pain After Spinal Cord Injury
Rintala, D. H., Fiess, R. N., Tan, G., Holmes, S. A., & Bruel, B. M. (2010) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3181f1c4ec · Cited by 108
Krcevski‐Škvarč, N., Wells, C., & Häuser, W. (2017) · European Journal of Pain · doi:10.1002/ejp.1147 · Cited by 99
Self-citationDon’t middle your MIDs: regression to the mean shrinks estimates of minimally important differences
Fayers, P. M., & Hays, R. D. (2014) · Quality of Life Research · doi:10.1007/s11136-013-0443-4 · Cited by 95
Hoggart, B., Ratcliffe, S. H., Ehler, E., Simpson, K. H., Hovorka, J., Lejčko, J., Taylor, L., Lauder, H., & Serpell, M. G. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7502-9 · Cited by 92
Häuser, W., Bartram, C., Bartram-Wunn, E., & Tölle, T. R. (2012) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3182321ad8 · Cited by 81
Self-citationPetzke, F., Enax-Krumova, E. K., & Häuser, W. (2016) · Der Schmerz · doi:10.1007/s00482-015-0089-y · Cited by 80
Self-citationOpioide bei chronischem neuropathischem Schmerz
Sommer, C., Welsch, P., Klose, P., Schaefert, R., Petzke, F. W., & Häuser, W. (2014) · Der Schmerz · doi:10.1007/s00482-014-1455-x · Cited by 76
Self-citationWhat is the meaning of “small fiber neuropathy” in fibromyalgia?
Clauw, D. J. (2015) · Pain · doi:10.1097/j.pain.0000000000000311 · Cited by 66
Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system
Smith, S. M., Amtmann, D., Askew, R. L., Gewandter, J. S., Hunsinger, M., Jensen, M. P., McDermott, M. P., Patel, K. V., Williams, M., Bacci, E. D., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000502 · Cited by 63
Zettl, U. K., Rommer, P. S., Hipp, P., & Patejdl, R. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285615612659 · Cited by 61
Neuropathic pain needs systematic classification
Finnerup, N. B., Scholz, J., Attal, N., Baron, R., Haanpää, M. L., Hansson, P. T., Raja, S. N., Rice, A. S. C., Rief, W., Rowbotham, M. C., et al. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00282.x · Cited by 60
Berger, A., Sadosky, A., Dukes, E. M., Edelsberg, J., & Oster, G. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-8 · Cited by 59
Medical use of cannabis products
Ablin, J. N., Ste‐Marie, P. A., Schäfer, M., Häuser, W., & Fitzcharles, M. (2016) · Der Schmerz · doi:10.1007/s00482-015-0083-4 · Cited by 59
Self-citationOpioide bei chronischem Arthroseschmerz
Schaefert, R., Welsch, P., Klose, P., Sommer, C., Petzke, F. W., & Häuser, W. (2014) · Der Schmerz · doi:10.1007/s00482-014-1451-1 · Cited by 57
Self-citationHäuser, W., Walitt, B. T., Klose, P., & Fitzcharles, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011694 · Cited by 51
Self-citationIndividualized Pharmacological Treatment of Neuropathic Pain
Helfert, S. M., Reimer, M., Höper, J., & Baron, R. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.19 · Cited by 45
Drug development: The treasure chest
Owens, B. (2015) · Nature · doi:10.1038/525s6a · Cited by 45
Hydromorphone for neuropathic pain in adults
Stannard, C., Gaskell, H., Derry, S., Aldington, D. J., Cole, P., Cooper, T. E., Knaggs, R., Wiffen, P. J., & Moore, R. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011604.pub2 · Cited by 44
Dronabinol and chronic pain: importance of mechanistic considerations
de Vries, M., van Rijckevorsel, D. C., Wilder‐Smith, O. H. G., & van Goor, H. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.918102 · Cited by 43
Chronic pain: genes, plasticity, and phenotypes
Baron, R., Wasner, G. L., & Binder, A. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70281-2 · Cited by 40
Albalawi, Z., McAlister, F. A., Thorlund, K., Wong, M. M., & Wetterslev, J. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.11.048 · Cited by 37
Clinical and Economic Characteristics of Patients with Painful Neuropathic Disorders in Germany
Berger, A., Toelle, T. R., Sadosky, A., Dukes, E. M., Edelsberg, J., & Oster, G. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00244.x · Cited by 35
The Dilemma of Medical Marijuana Use by Rheumatology Patients
Fitzcharles, M., Clauw, D. J., Ste‐Marie, P. A., & Shir, Y. (2014) · Arthritis Care & Research · doi:10.1002/acr.22267 · Cited by 27
Tyson, S. F., & Brown, P. (2013) · Clinical Rehabilitation · doi:10.1177/0269215513514231 · Cited by 27
Can Modulating Inflammatory Response be a Good Strategy to Treat Neuropathic Pain?
Zhang, J., Echeverry, S., Lim, T. K. Y., Lee, S., Shi, X., & Huang, H. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666141027115508 · Cited by 26
Pharmakoepidemiologische Forschung mit Routinedaten des Gesundheitswesens
Andersohn, F., & Garbe, E. (2008) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-008-0648-9 · Cited by 23
Cannabinoids for chronic neuropathic pain
Mücke, M., Phillips, T., Radbruch, L., Petzke, F. W., & Häuser, W. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012182 · Cited by 18
Self-citationClinical trial transparency: many gains but access to evidence for new medicines remains imperfect
Mintzes, B. J., Lexchin, J., & Santos, A. L. (2015) · British Medical Bulletin · doi:10.1093/bmb/ldv042 · Cited by 9
Cited by
Transition from acute to chronic pain after surgery
Glare, P., Aubrey, K. R., & Myles, P. S. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30352-6 · Cited by 914
Stockings, E., Campbell, G., Hall, W. D., Nielsen, S., Zagic, D., Rahman, R., Murnion, B., Farrell, M., Weier, M., & Degenhardt, L. (2018) · Pain · doi:10.1097/j.pain.0000000000001293 · Cited by 460
Cannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 376
Hall, W., Stjepanović, D., Caulkins, J., Lynskey, M., Leung, J., Campbell, G., & Degenhardt, L. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31789-1 · Cited by 357
Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Bruni, N., Della Pepa, C., Oliaro-Bosso, S., Pessione, E., Gastaldi, D., & Dosio, F. (2018) · Molecules · doi:10.3390/molecules23102478 · Cited by 272
Metadata
- Authors
- Mücke, M., Phillips, T., Radbruch, L., Petzke, F., & Häuser, W.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-03-07
- Volume
- 2020
- Issue
- 7
- Pages
- CD012182-CD012182
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2790816367
- Cited by
- 571
- References
- 138
- FWCI
- 36.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.